A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' Heart

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

September 12, 2018

Study Completion Date

September 12, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Cortexolone 17α-propionate solution

Single topical application to be applied twice daily (0 hour and 12 hour) on Days 1-3 and Once Daily (0 hour) on Day 4.

DRUG

Placebo

matching placebo

Trial Locations (1)

SW17 0RE

Richmond Pharmacology Ltd, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cassiopea SpA

INDUSTRY